AGAleksandra Gródek

Aleksandra Gródek

*This is an algorithmically generated author record based on publicly available information.

Aleksandra Gródek has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    OBESITY IN THE CHILDREN POPULATION AND ROBOTIC SURGERY: INFLUENCE ON THE COURSE OF THE PROCEDURE AND PROGNOSIS, NEW POSSIBILITIES IN BARIATRIC SURGERY - LITERATURE REVIEW

    by Marek Łobaziewicz, Patrycja Powaga, Dominik Zając, Dominika Darasz, Michał SęK, Aleksandra Wajs, Aleksandra Gródek, Julia Kierner

    Obesity is a disease that is becoming increasingly common among children and is associated with a number of complications such as hypertension, the development of type 2 diabetes, non-alcoholic fatty liver disease and respiratory disorders. One of the methods of treating both obesity and its complications are surgical operations, e.g. bariatric surgery, among which surgical robots are increasingly used tools. Robotic surgery is similarly effective to standard techniques and is often associated with a shorter hospital stay for overweight children, making it an increasingly common procedure; however, its costs remain significant. This article focuses on the use of robotic surgery in the treatment of obesity and its complications in children. We also discuss the advantages and limitations of this type of procedure.

  • Open Access

    TAURINE, BRANCHED-CHAIN AMINO ACIDS, AND BETA-ALANINE: AN EVALUATION OF THEIR EFFICACY AND APPLICATIONS IN SPORTS AND MEDICAL CONDITIONS. A REVIEW ARTICLE

    by Julia Jasińska, Dominik Iskrzyński, Aleksandra Bułat, Aleksandra Gródek, Julia Iglantowicz, Sylwia Sanakiewicz, Patryk Obajtek, Wiktoria Dubiel, Mikołaj Dubiel

    In recent years, the use of dietary supplements has increased substantially, both among professional athletes and individuals engaging in physical activity for recreational purposes. The aim of this study was to critically review the literature available in the PubMed database regarding the efficacy of taurine, beta-alanine, and branched-chain amino acid (BCAAs) supplementation in enhancing athletic performance, as well as their potential applications beyond sport, including in selected medical conditions. Analysis of the available evidence demonstrates that each of these compounds exerts distinct physiological effects and mechanisms of action. Taurine, due to its antioxidant properties and ability to modulate the inflammatory response, may support recovery processes and reduce the concentration of biomarkers associated with skeletal muscle damage. Beta-alanine, by enhancing intracellular hydrogen ion buffering capacity, appears to improve performance during high-intensity physical activity. In contrast, findings related to BCAA supplementation remain inconclusive. Although BCAAs may exhibit anabolic potential and contribute to reduction in post-exercise muscle soreness, current evidence does not demonstrate a consistent or significant effect on muscle strength or overall physical performance. Interpretation of available data is limited by considerable heterogeneity across studies, including small sample sizes, and the variability in supplementation protocols. Therefore, further studies with high methodological rigor are required to establish definitive conclusions regarding the efficacy and clinical relevance of these supplements.

  • Open Access

    Extracorporeal Blood Purification Techniques in Sepsis and ARDS: Evaluation of ECCO₂R and CytoSorb® Hemoadsorption – A Narrative Review

    by Julia Jasińska, Dominik Iskrzyński, Aleksandra Bułat, Aleksandra Gródek, Julia Iglantowicz, Sylwia Sanakiewicz, Patryk Obajtek, Wiktoria Dubiel, Mikołaj Dubiel

    Background: Sepsis is a life-threatening syndrome characterized by organ dysfunction resulting from a dysregulated host response to infection. It is associated with an imbalance between pro-inflammatory and anti-inflammatory pathways, leading to multiple organ injury, including acute kidney injury (AKI) and acute respiratory distress syndrome (ARDS). Despite advances in critical care medicine, sepsis remains one of the leading causes of mortality in intensive care units (ICUs). Increasing interest has focused on extracorporeal blood purification techniques aimed at modulating cytokine levels and facilitating carbon dioxide removal. Aim: The aim of this study was to provide an overview and critical evaluation of two extracorporeal blood purification modalities—extracorporeal carbon dioxide removal (ECCO₂R) and CytoSorb therapy. Materials and Methods: A narrative literature review was conducted using the PubMed database. Publications available up to April 2026 were identified using keywords related to CytoSorb, hemoadsorption, ECCO₂R, sepsis, ARDS, and critical care. Priority was given to systematic reviews, meta-analyses, randomized controlled trials, and observational studies. The retrieved evidence was synthesized narratively. Results: Both ECCO₂R, which facilitates carbon dioxide clearance, and CytoSorb hemoadsorption therapy, which removes circulating cytokines and inflammatory mediators, demonstrate high efficacy. However, current clinical trials have not shown significant improvements in mortality. This discrepancy may be related to patient heterogeneity and the lack of phenotype-based selection. ECCO₂R may be beneficial in ARDS phenotypes characterized by predominant hypercapnia, whereas CytoSorb therapy may be most effective in patients with the hyperinflammatory delta sepsis phenotype.

  • Open Access

    SGLT2 Inhibitors in the Management of Hypomagnesemia in Patients Without Diabetes. A Narrative Review

    by Aleksandra Wajs, Michał SęK, Maja Elertowicz, Dominika Darasz, Dominik Zając, Marek Łobaziewicz, Patrycja Powaga, Aleksandra Gródek, Julia Kierner

    Introduction: Hypomagnesemia remains an underdiagnosed and undertreated condition, despite its profound adverse health effects. Recently, sodium-glucose cotransporter 2 inhibitors have emerged as effective agents in elevating serum magnesium levels. Aim of the Study: The aim of the study is a critical appraisal of the literature regarding the efficacy of sodium-glucose cotransporter 2 inhibitors in elevating serum magnesium levels in hypomagnesemic, non-diabetic patients. Methods and Materials: A literature search was conducted across major electronic databases for randomized controlled studies, post-hoc analyses of randomized controlled studies, observational studies and case reports evaluating the effects of sodium-glucose cotransporter 2 inhibitors on serum magnesium levels, with particular attention to the non-diabetic patient population. Seven articles met the eligibility criteria and formed the basis of this review. Results: Available data suggest that the use of SGLT2 inhibitors in non-diabetic patients with hypomagnesemia was consistently associated with increased serum magnesium levels. Patients with lower baseline magnesium concentrations appeared to experience more pronounced improvement of serum magnesium levels, which increased predominantly early in treatment before stabilizing at a plateau. In addition, treatment with SGLT2 inhibitors was frequently associated with a reduced need for magnesium supplementation. In the reviewed literature, data on safety and adverse effects were limited. The included studies had important methodological limitations, including small sample sizes and a predominantly retrospective observational design. Therefore, further well-designed prospective studies are required to confirm the observed effects and better characterize the safety profile of SGLT2 inhibitors in this population.

  • Open Access

    Modern Perspectives on Diagnosing and Treating Dry Eye Disease in Elderly Patients

    by Aleksandra Gródek, Dominik Iskrzyński, Mikołaj Dubiel, Wiktoria Dubiel, Patryk Obajtek, Anna Sopel, Sylwia Sanakiewicz, Julia Iglantowicz, Aleksandra Bułat, Julia Jasińska

    Dry eye disease (DED) is a common multifactorial disorder of the ocular surface characterized by tear film instability, ocular discomfort, visual disturbance, and chronic inflammation. The aim of this review was to summarise current evidence regarding the pathophysiology, risk factors, diagnosis, and management of dry eye disease, with particular emphasis on its impact in the elderly population. Material and methods. A narrative literature review with PRISMA-informed methodology was conducted using PubMed, Web of Science, and Google Scholar. Literature published within the last 10 years concerning dry eye disease, ocular surface aging, meibomian gland dysfunction, and treatment strategies was analysed. Results. Dry eye disease is strongly associated with age-related changes in the lacrimal glands, meibomian glands, ocular surface epithelium, and neural regulation of tear secretion. Additional contributing factors include systemic comorbidities, polypharmacy, hormonal alterations, and environmental exposures. The most common clinical manifestations include ocular irritation, dryness, burning, foreign body sensation, fluctuating vision, and reduced visual quality, all of which can significantly impair daily functioning and quality of life. Diagnosis is based on a combination of patient-reported symptoms and clinical assessment of tear film stability and ocular surface integrity. Management strategies include environmental modifications, artificial tear supplementation, anti-inflammatory therapy, autologous serum eye drops, punctal occlusion, scleral lenses, and surgical options in severe or refractory cases. Conclusions. Dry eye disease in elderly patients is a progressive, multifactorial condition requiring early recognition and individualized, stepwise management to prevent disease progression and optimize quality of life.

  • Open Access

    THE ROLE OF NURSING ASSESSMENT IN DIAGNOSING INTESTINAL MALROTATION: A CASE REPORT

    by Sylwia Sanakiewicz, Patryk Obajtek, Mikołaj Dubiel, Julia Jasińska, Aleksandra Gródek, Dominik Iskrzyński, Aleksandra Bułat, Wiktoria Dubiel, Julia Iglantowicz

    Intestinal malrotation is a congenital anomaly of the gastrointestinal tract that is most commonly diagnosed during the neonatal period. Delayed presentation beyond infancy is uncommon and may result in significant diagnostic challenges, particularly in children with complex genetic disorders. This case describes a 4-year-old girl with Edwards syndrome (Trisomy 18) whose atypical presentation of intestinal malrotation created a demanding clinical situation for the multidisciplinary healthcare team. The patient was admitted to the pediatric surgical department with coffee-ground vomiting and a one-week history of constipation. Due to severe developmental impairment and limited communication abilities associated with her genetic condition, the assessment of symptoms relied heavily on careful clinical observation. The nursing team played a crucial role in the diagnostic process through comprehensive assessment, including pain evaluation using the FLACC scale, continuous monitoring of vital signs, and detailed observation of the frequency and characteristics of emesis. These findings raised suspicion of a high-level intestinal obstruction and prompted further diagnostic investigations. Although the initial abdominal X-ray suggested a diaphragmatic hernia, surgical exploration revealed intestinal malrotation with volvulus consistent with Ladd’s syndrome. This case highlights the importance of advanced nursing assessment, clinical vigilance, and interdisciplinary collaboration in recognizing rare surgical emergencies and ensuring patient safety in children with significant communication barriers and complex healthcare needs.

  • Open Access

    SECONDARY PAPILLARY THYROID CARCINOMA IN A NON-IRRADIATED PEDIATRIC LEUKEMIA SURVIVOR: CRITICAL IMPLICATIONS FOR ADVANCED NURSING SURVEILLANCE AND LONG-TERM SURVIVORSHIP PARADIGMS

    by Patryk Obajtek, Sylwia Sanakiewicz, Mikołaj Dubiel, Julia Jasińska, Aleksandra Gródek, Dominik Iskrzyński, Aleksandra Bułat, Wiktoria Dubiel, Julia Iglantowicz

    Objectives: This case study aims to document an extraordinary instance of early-onset secondary papillary thyroid carcinoma (PTC) in a non-irradiated pediatric survivor of acute lymphoblastic leukemia (ALL) and to evaluate its implications for advanced oncology nursing surveillance models. Methods: A descriptive, retrospective single-patient case study design was utilized. Clinical data, including multi-agent chemotherapy dosing protocols (ALL-IC BFM 2009), diagnostic radiologic logs, pre-operative thyroid function assays, and high-resolution ultrasonography parameters, were critically reviewed alongside post-operative histopathological data. Key Findings: A 3.5-year-old boy achieved molecular remission from B-cell ALL after exclusive chemotherapy, without any cranial or cervical irradiation. Remarkably, only 36 months post-primary diagnosis, proactive nursing physical palpation during a routine follow-up incidentally detected a firm cervical mass. High-resolution ultrasonography and fine-needle aspiration biopsy confirmed a metastatic classical variant of PTC (pT1bN1bM0). The patient successfully underwent a total thyroidectomy and modified cervical lymphadenectomy, achieving stable clinical remission over an 18-month longitudinal observation period. Conclusions: Secondary metastatic PTC can manifest exceptionally early in pediatric leukemia survivors, completely independent of prior exposure to ionizing radiation. This rapid oncogenesis challenges radiation-centric surveillance paradigms. To prevent diagnostic delays, we recommend the integration of regular, standardized manual thyroid palpation into routine nursing assessments for all pediatric oncology survivors. Future research must prioritize multi-center registries and routine molecular profiling to define chemotherapy-induced genotoxic thresholds and uncover underlying somatic-germline interactions in very young cohorts.

  • Open Access

    DIABETES MELLITUS IN WOLFRAM SYNDROME 1: CHARACTERISTICS AND PERSPECTIVES IN TREATMENT

    by Dominika Darasz, Dominik Zając, Marek Łobaziewicz, Patrycja Powaga, Michał SęK, Aleksandra Wajs, Aleksandra Gródek, Julia Kierner, Daria Valipur Kolti, Amelia Żurek

    Wolfram syndrome 1 is a rare autosomal recessive disorder caused by mutations in the WFS1 gene related to endoplasmic reticulum (ER) function. The course of the disease most often begins with diagnosis of insulin-dependent non-autoimmune diabetes mellitus with an early onset. Its clinical character is presented with an acronym DIDMOAD: diabetes insipidus (DI), diabetes mellitus (DM), optic atrophy (OA) and deafness (D). This article focuses on the clinical features of diabetes mellitus in Wolfram syndrome. We also describe current approach to its therapy and discuss possible treatment options placing the main emphasis on the GLP1 receptor agonists and cell regenerative therapy. Methods and materials: A qualitative synthesis of the data focusing on GLP-1 agonists, cell regenerative therapy and diabetes mellitus in Wolfram syndrome was performed. This literature review of GLP-1 receptor agonists and cell regenerative therapy effect on metabolic control, and current perspectives of treatment in patients with Wolfram syndrome, a monogenic type of diabetes, included recent publications, primarily from the past 10 years, and was conducted from November 2025 to April 2026 using the PubMed database. A systematic search was performed using specific keywords and medical subject headings (MeSH terms) related to GLP-1 agonists and Wolfram syndrome. The primary search terms included: “diabetes mellitus”, “GLP-1 agonists”, “Wolfram syndrome”, “WFS1”, “monogenic diabetes”, “islet transplantation”, and “cell regenerative therapy”. The criteria for inclusion of articles were as follows: published before April 2026, written in English, peer-reviewed original research articles. Exclusion criteria included publications not available in full text, articles in languages other than English. Editorials, commentaries, and conference abstracts without full data were also excluded. Titles and abstracts of the retrieved articles were screened to determine eligibility based on the inclusion and exclusion criteria.

  • Methods for reducing anxiety and pain in pediatric dentistry: a systematic review

    by Daria Kinga Wańczyk, Kinga Filip, Michał Sebastian Bochenek, Wojciech Franciszek Jakubowski, Sylwia Wiktoria Kolano, Jan Tomasik, Aleksandra Gródek, Mikołaj Dubiel

    Background: Dental anxiety is a common phenomenon among children and frequently leads to avoidance of dental visits, reduced cooperation during procedures, and deterioration of oral health. A lack of cooperation poses significant challenges for clinicians, affecting the course, duration, and overall effectiveness of treatment. Early identification and appropriate management of anxiety and pain are therefore essential to ensure successful dental care and to promote positive oral health behaviors later in life.Aim of the study: The aim of this systematic review is to summarize the available methods for reducing anxiety and pain in pediatric dentistry.Material and methods: This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The review protocol was developed a priori and defined the research question, eligibility criteria, data sources, search strategy, record management procedures, and methods of data synthesis.Results: Over the years, numerous strategies have been developed in pediatric dentistry to address these concerns, including both non-pharmacological and pharmacological approaches. Behavioral and communicative techniques, as well as various distraction methods such as audiovisual aids, virtual reality, and music therapy, are widely used to support anxious children and improve their experience in the dental setting. Relaxation strategies and parental involvement further contribute to enhancing patient comfort and reducing procedural distress.When behavioral approaches are insufficient, sedation or general anesthesia may be employed to facilitate safe and effective treatment, ensuring that necessary procedures can be completed without compromising the quality of care. Recent advances also include the introduction of modern digital tools and child-friendly technologies designed to create a supportive and engaging dental environment.Conclusions: This review summarizes current methods for reducing anxiety and pain in children undergoing dental treatment and highlights emerging developments aimed at improving patient experience and overall clinical outcomes.

  • Open Access

    THE IMPACT OF INR SELF-MONITORING (PATIENT SELF-TESTING AND SELF-MANAGEMENT) ON THE INCIDENCE OF THROMBOTIC AND HEMORRHAGIC COMPLICATIONS IN PATIENTS TREATED WITH VITAMIN K ANTAGONISTS: A LITERATURE REVIEW

    by Sylwia Wiktoria Kolano, Mikołaj Dubiel, Michał S. Bochenek, Wojciech Jakubowski, Jan T. Tomasik, Kinga Filip, Daria Wańczyk, Aleksandra Gródek

    Vitamin K antagonists (VKAs) remain essential in the management of patients with mechanical heart valves, rheumatic mitral stenosis, and selected cases of atrial fibrillation. Because therapeutic effectiveness depends on maintaining the international normalized ratio (INR) within a narrow target range, strategies that improve INR stability are critical to reducing the risks of thromboembolic and hemorrhagic complications. Traditional clinic-based monitoring is limited by infrequent testing and delayed dose adjustments, prompting growing interest in patient self-testing (PST) and patient self-management (PSM). This review assessed the impact of PST and PSM on anticoagulation quality and clinical outcomes in adults treated with VKAs. A targeted PubMed search (2015–2025) identified meta-analyses and randomized controlled trial evaluating INR self-monitoring. Three high-quality sources—a Cochrane review, a network meta-analysis, and a meta-analysis focused on telemedicine-supported PST—served as the primary evidence base. Across studies, both PST and PSM significantly increased time in therapeutic range (TTR), typically by 5–10 percentage points compared with standard care. PSM and telemedicine-assisted PST demonstrated the greatest improvements. Enhanced TTR translated into reductions in thromboembolic events, particularly in high-intensity PSM strategies. Importantly, no increase in major bleeding was observed in any self-monitoring model, indicating a favorable safety profile. In conclusion, INR self-monitoring, especially intensive PSM and telemedicine-enabled PST, offers an effective and safe approach to improving anticoagulation control in patients requiring long-term VKA therapy. These strategies address well-recognized limitations of traditional INR monitoring and support more responsive, patient-centered care.